Bitcoin News
By James Thorp
1 / 15
An Australian biotech company listed on the ASX has made a bold move to survive financial pressure by adopting a Bitcoin-focused strategy.
2 / 15
Bitcoin Treasury: A New Chapter for Opyl
3 / 15
Opyl disclosed it had acquired about two Bitcoins, worth roughly AU$330,000 (around $214,500), through the DigitalX Bitcoin ETF listed on the Australian Securities Exchange.
4 / 15
In response to the news, Opyl’s share price surged by over 47% in a single day. However, despite this sharp bounce, the stock is still trading more than 68% lower than where it…
5 / 15
The Bitcoin purchase was made possible through a non-dilutive loan backed by the company’s own holdings.
6 / 15
Desperate Times Call for Crypto Solutions
7 / 15
Opyl’s pivot to Bitcoin didn’t happen in a vacuum. The company is navigating dire financial conditions, ending the March quarter with only AU$64,000 (around $41,700 USD) in cash…
8 / 15
With few options left, Opyl’s decision reflects a growing trend among distressed firms using Bitcoin reserves as a hedge against instability and inflation.
9 / 15
Following the Path of Other Struggling Firms
10 / 15
Opyl joins a list of companies that have pivoted to Bitcoin during financial hardship. High-profile names like Michael Saylor’s firm MicroStrategy, which once saw stagnant…
11 / 15
This growing list of firms has helped shape the perception that Bitcoin can act as a hedge against both macroeconomic instability and internal business turbulence.
12 / 15
Bitcoin ETF Inflows Point to Broader Trend
13 / 15
Mike Eli, founder of crypto derivatives platform Coinperps, believes there is a measurable increase in companies adopting Bitcoin treasury strategies.
14 / 15
According to Eli, this pattern shows that companies are not just using Bitcoin to diversify, but are also trying to benefit from what he calls the “speculative premium” that…
15 / 15
While the Bitcoin strategy can provide short-term relief and generate optimism among investors, it isn’t without risk.
The Currency Analytics
Want the full story?